Literature DB >> 10454350

Antioxidants attenuate acute toxicity of tumor necrosis factor-alpha induced by brain injury in rat.

V Trembovler1, E Beit-Yannai, F Younis, R Gallily, M Horowitz, E Shohami.   

Abstract

Tumor necrosis factor-alpha alpha (TNF-alpha) and reactive oxygen species (ROS) are produced in the brain after traumatic injury and have deleterious effects. In a rat model of closed head injury (CHI), the synthetic antioxidant from the nitroxide family, Tempol, improved recovery and protected the blood-brain barrier. Similar protection was found after CHI in heat-acclimated rats, in which the endogenous antioxidants have been shown to be elevated after CHI. The present study examined the relationship between TNF-alpha and ROS after CHI, namely, whether after CHI, antioxidants that afforded cerebroprotection also attenuated brain levels of TNF-alpha. Three groups of rats were subjected to CHI: (1) control, nontreated, (2) Tempol-treated, and (3) heat-acclimated (30 days at 34 degrees C). Four hours after injury (time for peak production of TNF-alpha), the activity of TNF-alpha was measured. Although clinical recovery was facilitated in rats of the two treated groups, TNF-alpha activity was as high as in the traumatized, untreated rats. Moreover, direct injection of TNF-alpha into mouse brain induced disruption of the blood-brain barrier, indicating its acute harmful effect. This toxic effect was attenuated by before and after treatment with Tempol. Our results support the hypothesis that in vivo antioxidants neutralize TNF-alpha toxicity, probably by interfering with activation of the transcription factor NF-kappa-B.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454350     DOI: 10.1089/107999099313640

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  14 in total

Review 1.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

Review 2.  [Traumatic brain injury: impact on timing and modality of fracture care].

Authors:  P F Stahel; W Ertel; C E Heyde
Journal:  Orthopade       Date:  2005-09       Impact factor: 1.087

Review 3.  Endocannabinoids and traumatic brain injury.

Authors:  R Mechoulam; E Shohami
Journal:  Mol Neurobiol       Date:  2007-09-18       Impact factor: 5.590

4.  Resuscitation of traumatic brain injury and hemorrhagic shock with polynitroxylated albumin, hextend, hypertonic saline, and lactated Ringer's: Effects on acute hemodynamics, survival, and neuronal death in mice.

Authors:  Jennifer L Exo; David K Shellington; Hülya Bayir; Vincent A Vagni; Keri Janesco-Feldman; Lil Ma; Carleton J Hsia; Robert S B Clark; Larry W Jenkins; C Edward Dixon; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

Review 5.  Neuroinflammation in animal models of traumatic brain injury.

Authors:  Chong-Chi Chiu; Yi-En Liao; Ling-Yu Yang; Jing-Ya Wang; David Tweedie; Hanuma K Karnati; Nigel H Greig; Jia-Yi Wang
Journal:  J Neurosci Methods       Date:  2016-07-02       Impact factor: 2.390

6.  Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.

Authors:  Russell L Blaylock; Joseph Maroon
Journal:  Surg Neurol Int       Date:  2011-07-30

Review 7.  Inflammatory response following diffuse axonal injury.

Authors:  Yu Lin; Liang Wen
Journal:  Int J Med Sci       Date:  2013-03-13       Impact factor: 3.738

8.  The role of markers of inflammation in traumatic brain injury.

Authors:  Thomas Woodcock; Maria Cristina Morganti-Kossmann
Journal:  Front Neurol       Date:  2013-03-04       Impact factor: 4.003

Review 9.  Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis--there is nothing more practical than a good theory.

Authors:  Hülya Bayir; Valerian E Kagan
Journal:  Crit Care       Date:  2008-02-18       Impact factor: 9.097

10.  Chronic treatment with Tempol during acquisition or withdrawal from CPP abolishes the expression of cocaine reward and diminishes oxidative damage.

Authors:  Tehila Beiser; Ran Numa; Ron Kohen; Rami Yaka
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.